https://www.nasdaq.com/press-release/biodelivery-sciences-prevails-in-belbucar-anda-litigation-maintaining-patent
https://www.nasdaq.com/press-release/biodelivery-sciences-reports-solid-third-quarter-2021-results-2021-11-03
https://www.nasdaq.com/press-release/biodelivery-sciences-appoints-john-golubieski-as-chief-financial-officer-2021-10-21
https://www.nasdaq.com/press-release/biodelivery-sciences-to-report-third-quarter-2021-financial-results-on-november-3
https://www.nasdaq.com/press-release/biodelivery-sciences-international-to-host-elyxybtm-investor-day-2021-09-30
https://www.nasdaq.com/press-release/biodelivery-sciences-international-completes-acquisition-of-elyxybtm-for-acute
https://www.nasdaq.com/press-release/biodelivery-sciences-to-exhibit-three-scientific-posters-comparing-belbucar-to
https://www.nasdaq.com/press-release/biodelivery-sciences-to-participate-in-upcoming-virtual-investor-conferences-2021-09
https://www.nasdaq.com/press-release/azurrx-biopharma-announces-appointment-of-terry-coelho-to-its-board-of-directors-2021
https://www.nasdaq.com/press-release/biodelivery-sciences-reports-second-quarter-2021-results-2021-08-04
https://www.nasdaq.com/press-release/biodelivery-sciences-announces-agreement-to-acquire-u.s.-and-canadian-rights-to-fda
https://www.nasdaq.com/press-release/biodelivery-sciences-to-report-second-quarter-2021-financial-results-on-august-4-2021
https://www.nasdaq.com/press-release/biodelivery-sciences-reports-first-quarter-2021-results-2021-05-06
https://www.nasdaq.com/press-release/biodelivery-sciences-to-report-first-quarter-2021-financial-results-on-may-6-2021
https://www.nasdaq.com/press-release/biodelivery-sciences-reports-strong-q4-and-record-full-year-2020-results-2021-03-10
https://www.nasdaq.com/press-release/biodelivery-sciences-to-report-fourth-quarter-and-full-year-2020-financial-results-on
https://www.nasdaq.com/press-release/biodelivery-sciences-cfo-terry-coelho-promoted-to-executive-vice-president-2021-02-11
https://www.nasdaq.com/press-release/biodelivery-sciences-to-present-three-scientific-posters-comparing-belbucar-to
https://www.nasdaq.com/press-release/biodelivery-sciences-to-participate-in-the-piper-sandler-32nd-annual-healthcare
https://www.nasdaq.com/press-release/biodelivery-sciences-to-present-virtually-and-host-1x1-investor-meetings-at-the
https://www.nasdaq.com/press-release/biodelivery-sciences-reports-strong-q3-2020-results-2020-11-05
https://www.nasdaq.com/press-release/biodelivery-sciences-announces-%2425-million-share-repurchase-program-2020-11-04
https://www.nasdaq.com/press-release/biodelivery-sciences-announces-appointment-of-jeff-bailey-as-permanent-ceo-2020-11-04
https://www.nasdaq.com/press-release/biodelivery-sciences-to-report-third-quarter-2020-financial-results-on-november-5
https://www.nasdaq.com/press-release/biodelivery-sciences-announces-five-scientific-poster-presentations-at-painweekr-2020
https://www.nasdaq.com/press-release/biodelivery-sciences-to-present-at-two-upcoming-investor-conferences-2020-09-03
https://www.nasdaq.com/press-release/biodelivery-sciences-reports-strong-q2-2020-results-2020-08-05
https://www.nasdaq.com/press-release/biodelivery-sciences-to-report-second-quarter-2020-financial-results-on-august-5-2020
https://www.nasdaq.com/press-release/biodelivery-sciences-to-present-at-two-upcoming-investor-conferences-2020-05-29
https://www.nasdaq.com/press-release/biodelivery-sciences-appoints-jeff-bailey-interim-ceo-2020-05-11
https://www.nasdaq.com/press-release/biodelivery-sciences-reports-strong-q1-2020-results-2020-05-07
https://www.nasdaq.com/press-release/biodelivery-sciences-to-report-first-quarter-2020-financial-results-on-may-7-2020
https://www.nasdaq.com/press-release/biodelivery-sciences-reports-strong-fourth-quarter-and-full-year-2019-results-2020-03
https://www.nasdaq.com/press-release/biodelivery-sciences-appoints-jeffrey-a.-bailey-to-its-board-of-directors-2020-03-09
https://www.nasdaq.com/press-release/biodelivery-sciences-announces-phase-i-clinical-trial-results-at-the-american-academy
https://www.nasdaq.com/press-release/biodelivery-sciences-to-report-fourth-quarter-and-full-year-2019-financial-results-on
https://www.nasdaq.com/press-release/bdsi-expects-fourth-quarter-and-2019-total-net-sales-at-the-high-end-of-guidance%3a
https://www.nasdaq.com/press-release/biodelivery-sciences-appoints-kevin-ostrander-as-senior-vice-president-of-business
https://www.nasdaq.com/press-release/biodelivery-sciences-added-to-nasdaq-biotechnology-index-2019-12-19
https://www.nasdaq.com/press-release/biodelivery-sciences-to-present-at-the-piper-jaffray-31st-annual-healthcare
https://www.nasdaq.com/press-release/biodelivery-sciences-appoints-dr.-vanila-singh-former-chief-medical-officer-of-health
https://www.nasdaq.com/press-release/biodelivery-sciences-reports-strong-third-quarter-results-raises-full-year-2019-and
https://www.nasdaq.com/press-release/biodelivery-sciences-to-present-at-the-10th-annual-jefferies-global-healthcare
https://www.nasdaq.com/press-release/biodelivery-sciences-to-report-third-quarter-2019-financial-results-and-host
https://www.nasdaq.com/press-release/biodelivery-sciences-announces-significant-additional-insurance-coverage-for-both
https://www.nasdaq.com/press-release/biodelivery-sciences-announces-participation-in-upcoming-investor-conferences-2019-09
https://www.nasdaq.com/press-release/shareholder-alert%3a-purcell-julie-lefkowitz-llp-is-investigating-biodelivery-sciences
https://www.nasdaq.com/press-release/biodelivery-sciences-reports-strong-2018-results-and-2019-expectations-2019-04-21
